July 14, 2021
Drug Discovery & Development
Related News
-
July 13, 2026Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle® Platform
-
June 30, 2026
Cellares Accepted to FDA’s Inaugural Manufacturing PreCheck Cohort, the Only Cell Therapy Platform Among Seven Companies Nationwide
-
June 15, 2026
Cellares Grows Series D to $327 Million with $50 Million Prime Radiant Partners Investment
